Position in RPRX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$167,695,729
+$63,022,871 QoQ
Shares Held
3,495,846
+29.0% QoQ
Ownership
0.607%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Derivatives in RPRX
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$1,556,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. RPRX ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in RPRX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $167,695,729 | 3,495,846 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $104,672,858 | 2,708,925 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $93,378,114 | 2,646,772 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $73,549,620 | 2,041,344 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,556,500 | 50,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $125,316,396 | 4,025,583 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $76,162,271 | 2,985,585 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $57,561,800 | 2,034,705 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,230,347 | 2,018,595 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $57,801,455 | 1,903,242 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,752,562 | 1,343,986 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $40,581,733 | 1,495,274 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $47,540,359 | 1,546,531 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $67,823,229 | 1,882,410 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $52,305,745 | 1,323,526 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $60,251,755 | 1,499,546 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $68,900,488 | 1,638,927 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $76,382,169 | 1,960,528 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $74,570,864 | 1,871,289 | Shares | Defined | 2022-02-08 | |
| 2021-12-31 | $7,149,090 | 179,400 | Call | Defined | 2022-02-08 | |
| 2021-09-30 | $2,352,714 | 65,100 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $68,291,983 | 1,889,651 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $65,278,867 | 1,592,556 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $62,196,840 | 1,425,879 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,139,064 | 442,339 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $6,689,043 | 158,998 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $147,154 | 3,031 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||